Morgan Stanley (MS)
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-09-04
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-09-04
Research Workspace
Put MS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Investment Banking & Brokerage is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Net revenues reach about $70.6 billion: FY25 revenue guidance $70.6B vs $70.6B target.
View ThesisRevenue is growing steadily — about 9% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 27%, softest on free-cash-flow margins.
View QualityManagement screens strong on capital allocation, earnings delivery.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMorgan Stanley's growth has to keep compounding to justify the price. Revenue grew 27% year over year, and the last quarter beat expectations. It trades at 18× P/E versus a peer median of 21×. The price reflects less growth than forecasted, indicating modest expectations. The primary risk is that net revenues reached about $70.6 billion, matching the target but under pressure. Peer multiples imply a price about 13% below where it trades. This read is provisional; the thesis is on watch.
Trailing returns as of 2026-09-04. MS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 25 analysts currently covering MS (as of Sep 2026).
Based on 4 Wall Street analysts offering 12-month price targets for MS in the last 4 months.
Continue this research
Compare MS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Investment Banking & Brokerage — fair value, gap to price, and forward P/E.
Compare the value case
Put MS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase quarterly common stock dividend
Positive commentary on dividend growth supports dividend increase objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $217.72
The last 12 months of price, then the range of analyst 12-month targets from today’s $217.72.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Positive sentiment around Tesla can enhance MS's earnings.

Upgrade may enhance Morgan Stanley's investment thesis.

Negative verdict could impact investor confidence in MS.

AI refinancing may impact earnings performance negatively.

AI capital raising aligns with growth objectives.

Indicates potential for increased earnings performance.

Impressive results support strong quarterly earnings performance.
